The report "Wearable Injectors Market by Product Type(On-Body and Off-Body), Therapy (Immuno-oncology, Diabetes, Cardiovascular diseases), Technology(Spring-based, Motor Driven, Rotary Pump, Expanding Battery), Care Setting (Hospitals) - Global Forecast to 2026" The global wearable injectors market is projected to reach USD 11.5 billion by 2026 from USD 7.2 billion in 2021, at a CAGR of 9.9% during the forecast period. Growth in this market is mainly driven by factors such as the favorable reimbursement scenario in major markets and technological advancements in injector devices, advantages of wearable injectors in the administration of various drugs, and the rising prevalence of chronic diseases (such as cancer, diabetes, and CVD). However, a poor reimbursement structure in developing countries are expected to limit the adoption of wearable injectors to a certain extent.
Browse 110 market data Tables and 49 Figures spread through 189 Pages and in-depth TOC on "Wearable Injectors Market by Product Type(On-Body and Off-Body), Therapy (Immuno-oncology, Diabetes, Cardiovascular diseases), Technology(Spring-based, Motor Driven, Rotary Pump, Expanding Battery), Care Setting (Hospitals) - Global Forecast to 2026"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/wearable-injector-market-100771004.html
The on-body injectors segment dominated the wearable injectors market in 2020
The market is segmented based on type, technology, therapy, end user, and region. By type, the global wearable injectors market is segmented into on-body injectors and off-body injectors. The on-body injectors segment accounted for the largest share. The large share of this segment can be attributed to the the easy administration of viscous drugs and convenience to use at home and are comfortable to wear on the skin.
On the basis of technology, spring based segment accounted for the largest share of the wearable injectors market
Based on technology, the wearable injectors market is segmented into spring-based, motor-driven, rotary pump, expanding battery, and other technologies. The spring-based technology segment accounted for the largest share in the market. This can be attributed to the enabling the delivery of drugs with higher volume and viscosity and rising demand for adhesive patches.
On the basis of therapy, cardiovuscular diseases segment accounted for the largest share of the wearable injectors market
Based on therapy, the wearable injectors market is segmented into immuno-oncology, diabetes, cardiovascular diseases, and other therapies (such as Parkinson’s disease, thalassemia, and primary immunodeficiency disorders). The cardiovascular diseases segment accounted for the largest share. This can be attributed to high burden of cardiovascular diseases across the globe, coupled with the growing availability of wearable injectors for the treatment of these diseases.
The home healthcare settings segment is expected to grow at the highest CAGR
Based on end users, the wearable injectors market is segmented into hospitals and clinics and home healthcare settings. The home healthcare settings segment is expected to have the highest growth rate during the forecast period. This can primarily be attributed to the rising preference for the self-administration of medication and the increasing need to curb healthcare costs.
Europe is expected to grow at the highest CAGR during the forecast period
During the forecast period, the Europe is expected to be the fastest-growing regional market for wearable injectors. The growth of this market is attributed to the Increasing prevalence of chronic diseases, Government support for drug development in Germany, Rising focus on biosimilar innovation in the UK, Favourable reimbursement scenario for various treatment options in France.
Prominent players in the wearable injectors market include Amgen(California), Subcuject(Denmark), Enable Injections(Ohio), Medtronic Plc(Ireland), Insulet Corporation(US), United Therapeutics Corp (Us), CeQur SA(Switzerland), Sensile Medical(Switzerland).
Don’t miss out on business opportunities in Wearable Injectors Market. Speak to our analyst and gain crucial industry insights that will help your business grow.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441